Lonza Group Ltd (LZAGY)
62.99
+1.32
(+2.14%)
USD |
OTCM |
Nov 01, 16:00
Lonza Group Max Drawdown (5Y): 59.14% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 59.14% |
| September 30, 2024 | 59.14% |
| August 31, 2024 | 59.14% |
| July 31, 2024 | 59.14% |
| June 30, 2024 | 59.14% |
| May 31, 2024 | 59.14% |
| April 30, 2024 | 59.14% |
| March 31, 2024 | 59.14% |
| February 29, 2024 | 59.14% |
| January 31, 2024 | 59.14% |
| December 31, 2023 | 59.14% |
| November 30, 2023 | 59.14% |
| October 31, 2023 | 59.14% |
| September 30, 2023 | 47.98% |
| August 31, 2023 | 47.98% |
| July 31, 2023 | 47.98% |
| June 30, 2023 | 47.98% |
| May 31, 2023 | 47.98% |
| April 30, 2023 | 47.98% |
| March 31, 2023 | 47.98% |
| February 28, 2023 | 47.98% |
| January 31, 2023 | 47.98% |
| December 31, 2022 | 47.98% |
| November 30, 2022 | 47.98% |
| October 31, 2022 | 47.98% |
| Date | Value |
|---|---|
| September 30, 2022 | 47.98% |
| August 31, 2022 | 41.05% |
| July 31, 2022 | 41.05% |
| June 30, 2022 | 41.05% |
| May 31, 2022 | 38.72% |
| April 30, 2022 | 31.10% |
| March 31, 2022 | 27.18% |
| February 28, 2022 | 27.18% |
| January 31, 2022 | 27.18% |
| December 31, 2021 | 27.18% |
| November 30, 2021 | 27.18% |
| October 31, 2021 | 27.18% |
| September 30, 2021 | 27.18% |
| August 31, 2021 | 27.18% |
| July 31, 2021 | 27.18% |
| June 30, 2021 | 27.18% |
| May 31, 2021 | 27.18% |
| April 30, 2021 | 27.18% |
| March 31, 2021 | 27.18% |
| February 28, 2021 | 27.18% |
| January 31, 2021 | 27.18% |
| December 31, 2020 | 27.18% |
| November 30, 2020 | 27.18% |
| October 31, 2020 | 27.18% |
| September 30, 2020 | 27.18% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
27.18%
Minimum
Nov 2019
59.14%
Maximum
Oct 2023
39.56%
Average
34.91%
Median
Max Drawdown (5Y) Benchmarks
| AC Immune SA | 89.55% |
| CRISPR Therapeutics AG | 81.61% |
| Addex Therapeutics Ltd | -- |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -3.210 |
| Beta (5Y) | 0.9914 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 34.36% |
| Historical Sharpe Ratio (5Y) | 0.2791 |
| Historical Sortino (5Y) | 0.4337 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.39% |